Page last updated: 2024-08-26

bosentan anhydrous and Elevated Cholesterol

bosentan anhydrous has been researched along with Elevated Cholesterol in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Best, PJ; Cannan, CR; Hasdai, D; Holmes, DR; Lerman, A; Mathew, V; Schwartz, RS	1
Best, PJ; Hasdai, D; Holmes, DR; Lerman, A; McKenna, CJ	1
Calvert, RC; Khan, MA; Mikhailidis, DP; Morgan, RJ; Mumtaz, FH; Sullivan, ME; Thompson, CS	1

Reviews

1 review(s) available for bosentan anhydrous and Elevated Cholesterol

Article	Year
Normal and pathological erectile function: the potential clinical role of endothelin-1 antagonists. Current drug targets, 2000, Volume: 1, Issue:3 Topics: Animals; Antihypertensive Agents; Bosentan; Diabetes Complications; Diabetes Mellitus; Endothelin-1; Erectile Dysfunction; Humans; Hypercholesterolemia; Hypertension; Male; Myocardial Ischemia; Neural Pathways; Nitric Oxide; Penile Erection; Risk Factors; Smoking; Sulfonamides	2000

Article

Year

Normal and pathological erectile function: the potential clinical role of endothelin-1 antagonists.

Current drug targets, 2000, Volume: 1, Issue:3

Topics: Animals; Antihypertensive Agents; Bosentan; Diabetes Complications; Diabetes Mellitus; Endothelin-1; Erectile Dysfunction; Humans; Hypercholesterolemia; Hypertension; Male; Myocardial Ischemia; Neural Pathways; Nitric Oxide; Penile Erection; Risk Factors; Smoking; Sulfonamides

2000

Other Studies

2 other study(ies) available for bosentan anhydrous and Elevated Cholesterol

Article	Year
Acute endothelin-receptor inhibition does not attenuate acetylcholine-induced coronary vasoconstriction in experimental hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology, 1998, Volume: 18, Issue:1 Topics: Acetylcholine; Animals; Antihypertensive Agents; Azepines; Blood Pressure; Bosentan; Cholesterol; Coronary Vessels; Diet, Atherogenic; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Hypercholesterolemia; Indoles; Receptors, Endothelin; Sulfonamides; Swine; Vasoconstriction; Vasoconstrictor Agents; Viper Venoms	1998
Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia. Circulation, 1999, Apr-06, Volume: 99, Issue:13 Topics: Administration, Oral; Animals; Atrasentan; Bosentan; Coronary Vessels; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelium, Vascular; Hemodynamics; Hypercholesterolemia; Pyrrolidines; Random Allocation; Receptor, Endothelin A; Sulfonamides; Swine	1999

Article

Year

Acute endothelin-receptor inhibition does not attenuate acetylcholine-induced coronary vasoconstriction in experimental hypercholesterolemia.

Arteriosclerosis, thrombosis, and vascular biology, 1998, Volume: 18, Issue:1

Topics: Acetylcholine; Animals; Antihypertensive Agents; Azepines; Blood Pressure; Bosentan; Cholesterol; Coronary Vessels; Diet, Atherogenic; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Hypercholesterolemia; Indoles; Receptors, Endothelin; Sulfonamides; Swine; Vasoconstriction; Vasoconstrictor Agents; Viper Venoms

1998

Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia.

Circulation, 1999, Apr-06, Volume: 99, Issue:13

Topics: Administration, Oral; Animals; Atrasentan; Bosentan; Coronary Vessels; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelium, Vascular; Hemodynamics; Hypercholesterolemia; Pyrrolidines; Random Allocation; Receptor, Endothelin A; Sulfonamides; Swine

1999